Table1 Atrial mass cases diagnosed by intravenous biopsy
Age | Sex | Biopsy location | Transvenous pathway | Guidance Method | Presenting reasons | Pathological diagnosis | Treatment | Outcome | PMID |
|---|---|---|---|---|---|---|---|---|---|
14 | Male | RA | Femoral vein | DSA + TEE | Chest pain, cough, and hemoptysis | / | / | / | 2,334,836 [18] |
46 | Female | RA | Jugular vein | DSA | Symptoms of Upper respiratory infection | Metastases of melanoma | / | / | 2,765,329 [16] |
83 | Female | RA | Femoral vein | DSA | Dyspnea and hypodynamia | Papillary fibroelastoma | Symptomatic treatment | / | 2,816,690 [19] |
69 | Female | RA | Femoral vein | DSA + TEE | Dyspnea, edema, and syncope | Thrombus | Surgical resection | Remission | 7,499,910 [20] |
52 | Female | RA | Femoral vein | DSA + TEE | History of cirrhosis | Metastases of liver cancer | / | Deceased | 8,131,572 [21] |
69 | Male | RA | Femoral vein | DSA + TEE | Dyspnea, cough, and hemoptysis | Metastases of melanoma | / | / | 8,154,436 [22] |
69 | Female | RA | Jugular vein | DSA + TEE | Dyspnea, dehydration, and ventricular tachycardia | Thrombus | Symptomatic treatment | / | 8,365,328 [23] |
62 | Male | RA | Jugular vein | DSA + TEE | Edema and hepatic encephalopathy | Metastatic adenocarcinoma | / | Deceased | 8,498,328 [24] |
73 | Female | RA | Jugular vein | DSA + TEE | Edema, cough, fever, and dyspnea | Lymphoma | Chemotherapy | Remission | 8,579,042 [25] |
69 | Male | RA | Femoral vein | DSA + ICE | Flu symptoms | Metastasis of lung cancer | / | / | 8,611,294 [26] |
73 | Male | RA | Jugular vein | DSA + TEE | Asymptomatic | Metastases of melanoma | Chemotherapy | / | 8,945,488 [27] |
35 | Male | RA | Femoral vein | DSA + TEE | Dyspnea and cough | Angiosarcoma | Chemotherapy | Remission | 8,974,823 [28] |
/ | / | RA | Jugular vein | DSA + TEE | / | Angiosarcoma | / | / | 9,070,559 [29] |
62 | Male | RA | Jugular vein | DSA + TEE | Dyspnea, chest pain and | Undifferentiated sarcoma | Chemotherapy | Deceased | 9,339,428 [30] |
66 | / | RA + AS | Femoral vein | DSA + TEE | Myocardial infarction | Lymphoma | Chemotherapy | / | 9,454,452 [31] |
64 | Female | RA | / | DSA + TEE | Dizziness | Lymphoma | / | / | 9,487,479 [32] |
47 | Male | RA | Jugular vein | DSA + TTE | Dyspnea, edema and pleural effusion | Lymphoma | Chemotherapy | / | 9,829,904 [33] |
50 | Male | RA | / | DSA + TEE | Orthopnea, fever, and pleural effusion | Thrombus | Surgical resection | Deceased | 9,932,633 [34] |
39 | Female | / | / | / | / | Myxoma | / | / | 10,231,677 [35] |
/ | / | RA | / | / | / | / | / | / | 10,763,354 [36] |
77 | Female | RA | / | DSA + TEE | Dyspnea, edema and hypodynamia | Lymphoma | Chemoradiotherapy | Remission | 10,790,358 [37] |
75 | Male | RA | Femoral vein | DSA + TEE | Hemoptysis | Lymphoma | Chemotherapy | Remission | 10,842,397 [38] |
79 | Female | RA | Femoral vein | DSA + ICE | Dyspnea and edema | Neuroblastoma | / | / | 10,952,166 [39] |
/ | / | LA | / | DSA + TEE | / | Atrial sarcoma | / | / | 11,223,492 [40] |
52 | Male | RA | Jugular vein | DSA + TEE | Epigastric ache | Angiosarcoma | Chemotherapy | Remission | 12,019,433 [41] |
62 | Male | RA | Femoral vein | DSA + TEE | Dyspnea and dizziness | Lymphoma | Chemotherapy | Remission | 12,848,708 [42] |
64 | Male | RA | Jugular vein | DSA + TEE | Heart failure | Lymphoma | Chemotherapy | Remission | 14,622,547 [43] |
52 | Male | RA | Jugular vein | DSA + TEE | Dyspnea, chest pain, and edema | Metastases of liver cancer | Symptomatic treatment | Deceased | 15,546,373 [44] |
63 | Female | RA | Jugular vein | DSA + ICE | Dyspnea and centrum fracture | Lipomyoma | Expectant treatment | / | 16,880,106 [45] |
61 | Male | RA | Subclavian vein for biopsy, femoral vein for ICE | DSA + ICE | Ventricular tachycardia | Lymphoma | / | / | 17,015,040 [46] |
38 | Male | RA | / | DSA + TTE | Dyspnea | Lymphoma | Chemotherapy | Remission | 17,383,751 [47] |
52 | Male | RA | Femoral vein | DSA + ICE | Cardiac tamponade | Granulocytic sarcoma | Chemoradiotherapy and hematopoietic stem cell transplantation | Remission | 18,498,027 [48] |
56 | Female | / | / | / | Repeated pericardial effusion | / | / | / | 18,805,775 [49] |
67 | Female | RA | Jugular vein for biopsy, femoral vein for ICE | DSA + ICE | The discomfort of the precordial area | Paragangliomas | Surgical resection | / | 18,818,096 [17] |
47 | Female | RA | Jugular vein for biopsy, femoral vein for ICE | DSA + ICE | Hypodynamia and atrial fibrillation | Paragangliomas | Surgical resection | / | 18,818,096 [17] |
30 | Male | RA/IVC | Jugular vein for biopsy, femoral vein for ICE | DSA + ICE | Polyserositis and edema after heart transplant | Bacterial emboli | Surgical resection | Remission | 18,818,096 [17] |
70 | Male | RA/IVC | / | / | Ascites after heart transplantation | Cardiac amyloidosis | Symptomatic treatment | Deceased | 18,818,096 [17] |
63 | Female | RA | Jugular vein for biopsy, femoral vein for ICE | DSA + ICE | Chest discomfort and edema | Lymphoma | Chemotherapy | Remission | 19,057,087 [50] |
59 | Male | RA | / | DSA + TEE | Dyspnea, cough, chest discomfort, fever and hypodynamia | Lymphoma | Chemotherapy | Remission | 19,142,595 [51] |
64 | Female | RA | / | DSA + TTE | Dizziness and history of endometrial carcinoma | Metastases of endometrial adenocarcinoma | / |  | 20,027,104 [52] |
22 | Female | RA | / | DSA + ICE | Dyspnea and syncope | Angiosarcoma | Chemotherapy | / | 20,585,357 [53] |
57 | Female | RA | / | DSA + TEE | Dyspnea and back pain | Intimal sarcoma | Chemotherapy | Remission | 20,966,612 [54] |
44 | Male | RA | Jugular vein for biopsy, femoral vein for ICE | DSA + ICE | Dyspnea | Lymphoma | Chemotherapy | Remission | 22,576,384 [55] |
31 | Male | LA | / | DSA + TEE | Dyspnea and hypodynamia | Poorly differentiated sarcoma | Chemotherapy | Deceased | 23,109,774 [56] |
46 | Male | RA | Femoral vein | DSA + ICE | History of myxoma | Myxoma | Expectant treatment | Remission | 25,240,574 [57] |
53 | Male | RA | Right femoral vein for biopsy, left femoral vein for ICE | DSA + ICE | Dyspnea and weight loss | Metastases of lung cancer | Chemotherapy | Deceased | 25,810,740 [58] |
51 | Female | RA | / | DSA + ICE | Dyspnea and edema | Angiosarcoma | Chemotherapy | Deceased | 25,810,740 [58] |
47 | Female | RA | Femoral vein | DSA + ICE | Neoadjuvant chemotherapy for breast cancer | Thrombus | Surgical resection | Remission | 27,068,834 [59] |
59 | Male | LA | / | DSA + TEE | Fever, weight loss, and history of HIV infection | Lymphoma | Chemotherapy | Remission | 31,020,117 [60] |
61 | Male | RA | / | DSA + ICE | Jaundice, hypodynamia and diagnosed as IgG4/related disease | IgG4/related disease | Hormonotherapy | Remission | 31,118,383 [61] |
47 | Female | RA | Jugular vein for biopsy, femoral vein for ICE | DSA + ICE | Cough and pulmonary nodules | Angiosarcoma | Chemotherapy | Remission | 32,874,873 [62] |
48 | Male | RA | Femoral vein and jugular vein | DSA + TTE | Palpitation and chest discomfort | Intimal sarcoma | Chemotherapy | Remission | Present case |
77 | Female | RA | Jugular vein | DSA + TTE | Dyspnea and chest discomfort | Lymphoma | Chemotherapy | Remission | Present case |